As adoption of drugs like Ozempic, Wegovy, and Mounjaro increases, eating patterns are shifting toward smaller portions, higher protein intake, and fiber-rich foods that support satiety
The low molecular weight phthalates (for example, diethyl phthalate, di-isobutyl phthalate, and di-n-butyl phthalate) are often used in non-PVC applications, such as certain dietary supplements, personal care products and enteric-coated tablets (82)
Earlier this year, Point32 announced Zepbound would be its preferred GLP-1 drug to treat overweight or obesity in adults, mandating patients switch from other options, such as Wegovy or Saxenda
approximately 20% of the population with type 2 diabetes for SGLT2is and approximately 5% for GLP-1 RAs [9]